GV 2019 Gp, LLC, 10% Owner at Prime Medicine, Inc. (PRME), sold 88,221 shares at $13.70 ($806K) on 2023-05-26, disclosed to the SEC on 2023-05-31.
Scheduled sale ($806k) by 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 12,602 | $0 | 0.0% |
| 2 | $13.70 | 12,602 | $173K | 21.4% |
| 3 | $13.70 | 12,602 | $173K | 21.4% |
| 4 | $0.00 | 16,805 | $0 | 0.0% |
| 5 | $13.70 | 16,805 | $230K | 28.6% |
| 6 | $13.70 | 16,805 |
| $230K |
| 28.6% |
| Total | $9.13 avg | 88,221 | $806K | 100% |
| Filing → |
| LIFE | SELL | 2026-07-23 | $1.4M | — | Filing → |
| LIFE | SELL | 2026-07-21 | $730K | — | Filing → |
| LIFE | SELL | 2026-07-17 | $1.8M | — | Filing → |